These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4613746)

  • 1. Comparison of cationic-surfactant and phenol-based mouthwash-gargles in relieving oropharyngeal pain.
    Breazeale J
    J Am Coll Health Assoc; 1974 Dec; 23(2):165-6. PubMed ID: 4613746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind study on the efficacy of Imposit throat tablets in acute lesions of the upper respiratory tract].
    Alexanderson O; Nermark J; Lund
    Med Welt; 1975 Sep; 26(36):1619-24. PubMed ID: 51461
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind crossover trial on the effect of cetylpyridinium chloride 0.05 per cent (Merocet) on plaque accumulation.
    Llewelyn J
    Br Dent J; 1980 Feb; 148(4):103-4. PubMed ID: 6986884
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of inflammatory mouth and pharyngeal diseases with Imposit].
    Wasilewski A; Zawodsky L
    Ther Ggw; 1976 Nov; 115(11):1933-40. PubMed ID: 63154
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical reduction of gingivitis through the use of a mouthwash containing two quaternary ammonium compounds.
    Rosa M; Sturzenberger OP
    J Periodontol; 1976 Sep; 47(9):535-7. PubMed ID: 1067409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of inflammatory diseases in the mouth and pharynx using Imposit].
    Stricker G; Ravanelli O
    Ther Ggw; 1975 Jan; 114(1):71-2, 75-6, 78 passim. PubMed ID: 46626
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with Imposit in the treatment of inflammatory involvements in the oral and pharyngeal area].
    Heim G
    Ther Ggw; 1975 Mar; 114(3):411-2, 415-6, 418 PASSIM. PubMed ID: 47655
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of two cetylpyridinium chloride-containing mouthwashes on bacterial plaque.
    Barnes GP; Roberts DW; Katz RV; Woolridge ED
    J Periodontol; 1976 Jul; 47(7):419-22. PubMed ID: 1065740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of inflammatory lesions of the mouth and pharynx using Imposit].
    Vorberg G
    Ther Ggw; 1977 Oct; 116(10):1896-904. PubMed ID: 72421
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of a 0.1% cetylpyridinium chloride mouthrinse on plaque and gingivitis in adult subjects.
    Ashley FP; Skinner A; Jackson P; Woods A; Wilson RF
    Br Dent J; 1984 Sep; 157(6):191-6. PubMed ID: 6593085
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of cetylpridinium chloride on human plaque bacteria and gingivitis.
    Lobene RR; Kashket S; Soparkar PM; Shloss J; Sabine ZM
    Pharmacol Ther Dent; 1979; 4(1):33-47. PubMed ID: 295121
    [No Abstract]   [Full Text] [Related]  

  • 12. The local anaesthetic effects of cepacaine in post-tonsillectomy cases, pharyngitis and minor infections of the mouth.
    Janecke JB
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):70-3. PubMed ID: 821708
    [No Abstract]   [Full Text] [Related]  

  • 13. [Testing of the effect of Imposit throat tablets in double-blind test].
    Haglind K; Gruber P
    Z Allgemeinmed; 1975 Sep; 51(27):1211-4. PubMed ID: 53945
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of a cetylpyridinium dentifrice].
    Rebstein F; de Crousaz P; Corti M; Jaccard F; Matter J; Huber P; Cimasoni G
    SSO Schweiz Monatsschr Zahnheilkd; 1981 Jan; 91(1):51-7. PubMed ID: 7017921
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of two alcohol-free cetylpyridinium chloride mouthwashes - a randomized double-blind crossover study.
    Rawlinson A; Pollington S; Walsh TF; Lamb DJ; Marlow I; Haywood J; Wright P
    J Clin Periodontol; 2008 Mar; 35(3):230-5. PubMed ID: 18190554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cetylpyridinium chloride mouthwashes. Comparative effects of scaling alone or with mouthwash].
    Hitzig C; Charbit Y; Varonne R; Teboul M; Souci J; Bitton C; Brumpt P; Douider N
    Inf Dent; 1991 May; 73(19):1499-502. PubMed ID: 2045183
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of tserigel in the combined treatment of patients with erysipelatous inflammation].
    Zimnenko PA; Sen'ko VP; Mochalov NI
    Vestn Khir Im I I Grek; 1986 Feb; 136(2):66. PubMed ID: 3705346
    [No Abstract]   [Full Text] [Related]  

  • 18. Two independent clinical trials comparing pre-brush mouthrinse formulations in reducing supragingival plaque.
    Cronin M; Gordon J; Fernandez P
    J Can Dent Assoc; 1997 May; 63(5):347-55. PubMed ID: 9170750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of tserigel in treating facial burns].
    Arifdzhanov AK; Nigmanov ShKh
    Stomatologiia (Mosk); 1984; 63(5):48-9. PubMed ID: 6593920
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protective effect against bacterial plaque accumulation of a mouthwash containing cetylpyridinium].
    Gargiulo V; De Notaris V; Cassese G; Serra G; Silvano G; Celeste G; Battista F; Russo M
    Minerva Stomatol; 1980; 29(1):39-44. PubMed ID: 7005652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.